Related Experiment Videos
[Recent progress in the development of anti-tumor metastatic drugs]
1Research Center, Asahi Glass Co., Ltd., Yokohama, Japan.
Abstract:
Metastasis is often a terminal stage of cancer when tumor fragments lodge and grow in different parts of the body. There is currently no way to prevent metastasis, and there are few effective treatments. We believe that it is very important to develop an anti-tumor metastatic drug. Recent studies on the mechanism of tumor metastasis reveal that this multi-step process requires complex interaction between the tumor cells and their environment. In vitro experiments and animal cancer model studies have shown that the inhibitors of invasion (including adhesion, proteolysis, and migration) and neovascularization may suppress tumor metastasis. The author show a the mechanism of tumor metastasis, an in vitro screening method, and the recent progress of the development of various candidate anti-tumor metastatic drugs, including invasion inhibiting factor-2. Finally, the importance of the development of an anti-tumor metastatic drug in Japan is underscored.
Insights
Developing anti-tumor metastatic drugs is crucial as cancer metastasis has no current prevention or effective treatments. Research explores inhibiting tumor invasion and neovascularization to suppress metastasis.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Context:
- Metastasis is a critical, often fatal, stage of cancer characterized by tumor spread.
- Current therapeutic strategies for preventing or treating metastasis are limited.
- Understanding the complex tumor microenvironment interactions is key to developing anti-metastatic drugs.
Purpose:
- To review the mechanism of tumor metastasis.
- To present an in vitro screening method for anti-metastatic agents.
- To highlight recent advancements in developing novel anti-tumor metastatic drugs.
Summary:
- This review details the multi-step process of cancer metastasis, emphasizing the intricate interplay between tumor cells and their environment.
- It introduces an in vitro screening approach to identify potential metastasis inhibitors.
- Recent progress in developing candidate drugs, such as invasion inhibiting factor-2, is discussed, focusing on inhibiting invasion and neovascularization.
Impact:
- The development of effective anti-tumor metastatic drugs is urgently needed to improve patient outcomes.
- This research provides a foundation for future drug discovery targeting cancer spread.
- Highlights the importance of developing anti-metastatic therapies, particularly in Japan.